These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 39098687)
1. UBE2S facilitates glioblastoma progression through activation of the NF-κB pathway via attenuating K11-linked ubiquitination of AKIP1. Han Z; Xu L; Wang A; Wang B; Liu Q; Liu H; Liu Q; Gang Z; Yu S; Mu L; Weng C; Lin Z; Hu L Int J Biol Macromol; 2024 Oct; 278(Pt 1):134426. PubMed ID: 39098687 [TBL] [Abstract][Full Text] [Related]
2. UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells. Ho JY; Lu HY; Cheng HH; Kuo YC; Lee YA; Cheng CH Cell Oncol (Dordr); 2021 Dec; 44(6):1325-1338. PubMed ID: 34582005 [TBL] [Abstract][Full Text] [Related]
3. CD2AP promotes the progression of glioblastoma multiforme via TRIM5-mediated NF-kB signaling. Zhang L; He J; Zhao W; Zhou Y; Li J; Li S; Zhao W; Zhang L; Tang Z; Tan G; Chen S; Zhang B; Zhang YW; Wang Z Cell Death Dis; 2024 Oct; 15(10):722. PubMed ID: 39353894 [TBL] [Abstract][Full Text] [Related]
4. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer. Zhang X; Liu S; Zhu Y Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379 [TBL] [Abstract][Full Text] [Related]
5. Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma. Xiao F; Zhu H; Xiong Y; Guo Y; Zhang Z; Zeng J; Xiao Y; Liao B; Shang X; Zhao S; Hu G; Huang K; Guo H J Exp Clin Cancer Res; 2024 Jul; 43(1):187. PubMed ID: 38965580 [TBL] [Abstract][Full Text] [Related]
6. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways. Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353 [TBL] [Abstract][Full Text] [Related]
7. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα. Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880 [TBL] [Abstract][Full Text] [Related]
8. Small GTPase RHOE/RND3, a new critical regulator of NF-κB signalling in glioblastoma multiforme? Sun Q; Dong H; Li Y; Yuan F; Xu Y; Mao S; Xiong X; Chen Q; Liu B Cell Prolif; 2019 Sep; 52(5):e12665. PubMed ID: 31332862 [TBL] [Abstract][Full Text] [Related]
9. A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling. Gao N; Hibi Y; Cueno M; Asamitsu K; Okamoto T J Biol Chem; 2010 Sep; 285(36):28097-104. PubMed ID: 20562110 [TBL] [Abstract][Full Text] [Related]
10. AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65. Gao N; Asamitsu K; Hibi Y; Ueno T; Okamoto T J Biol Chem; 2008 Mar; 283(12):7834-43. PubMed ID: 18178962 [TBL] [Abstract][Full Text] [Related]
11. UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer. Xiao K; Peng S; Lu J; Zhou T; Hong X; Chen S; Liu G; Li H; Huang J; Chen X; Lin T Cell Death Dis; 2023 Jul; 14(7):408. PubMed ID: 37422473 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive Investigation into the Role of Ubiquitin-Conjugating Enzyme E2S in Melanoma Development. Wang P; Li Y; Ma Y; Zhang X; Li Z; Yu W; Zhu M; Wang J; Xu Y; Xu A J Invest Dermatol; 2021 Feb; 141(2):374-384. PubMed ID: 32603752 [TBL] [Abstract][Full Text] [Related]
13. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop. Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050 [TBL] [Abstract][Full Text] [Related]
14. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression. Wan S; Liu C; Li C; Wang Z; Zhao G; Li J; Ran W; Zhong X; Li Y; Zhang L; Cui H Oncogene; 2023 Sep; 42(39):2905-2918. PubMed ID: 37596322 [TBL] [Abstract][Full Text] [Related]
15. The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity. Hu Y; Zhang B; Lu P; Wang J; Chen C; Yin Y; Wan Q; Wang J; Jiao J; Fang X; Pu Z; Gong L; Ji L; Zhu L; Zhang R; Zhang J; Yang X; Wang Q; Huang Z; Zou J Clin Transl Med; 2022 Sep; 12(9):e1042. PubMed ID: 36116131 [TBL] [Abstract][Full Text] [Related]
16. Interaction of NF-κB and FOSL1 drives glioma stemness. Ramar V; Guo S; Hudson B; Khedri A; Guo AA; Li J; Liu M Cell Mol Life Sci; 2024 Jun; 81(1):255. PubMed ID: 38856747 [TBL] [Abstract][Full Text] [Related]
17. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
18. UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy. Hu L; Li X; Liu Q; Xu J; Ge H; Wang Z; Wang H; Wang Z; Shi C; Xu X; Huang J; Lin Z; Pieper RO; Weng C Oncogene; 2017 Feb; 36(8):1145-1156. PubMed ID: 27593939 [TBL] [Abstract][Full Text] [Related]
19. PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma. Yi K; Cui X; Liu X; Wang Y; Zhao J; Yang S; Xu C; Yang E; Xiao M; Hong B; Fang C; Kang C; Tan Y; Wang Q Front Immunol; 2021; 12():802795. PubMed ID: 35069587 [TBL] [Abstract][Full Text] [Related]
20. TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase. Wang W; Huang X; Xin HB; Fu M; Xue A; Wu ZH J Biol Chem; 2015 May; 290(21):13372-85. PubMed ID: 25861989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]